The Chinese company Landwind Medical is one of the first companies in the world that found a solution for the quantitative determination of neutralizing antibodies that have proven to be the best indicator of the vaccination efficiency.
Landwind Anti-SARS-CoV-2 Neutralizing Antibodies – The ELISA Kit is a test designed to quantitatively detect neutralizing antibodies against the SARS-CoV-2 virus in human serum or plasma.
New research shows that neutralizing antibodies are antibodies that provides the best protection against the virus. These antibodies, in the case of infection from COVID-19, recognize the virus and bind to the spike protein on it’s surface, which virus uses to enter the host cells. In order to achieve sterilizing immunity, vaccines must stimulate a sufficient amount of neutralizing antibodies, which are the only ones that have the ability to capture virus particles that enter the body and prevent further infection of the organism with the virus. The Landwind Anti-SARS-CoV-2 Neutralizing Antibody ELISA Kit that specifically detects these antibodies is used to assess the effectiveness of vaccination and possibly predict for how long protection against the virus will last. The test has a high sensitivity for antibody detection which greatly improves the screening speed.
All other informations are available on the website: www.landwindmedical.com
